Aktie 300318 BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Beijing Bohui Innovation Biotechnology Group Co., Ltd.

Aktien

300318

CNE000001QR4

300318

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 23.04.2024 		% 5 Tage % 1. Jan.
4.63 CNY +0.43% Intraday Chart für Beijing Bohui Innovation Biotechnology Group Co., Ltd. -0.22% -25.80%
2023 Bohui Innovation Biotechnology erhält Lizenz zur Blutsammlung in der chinesischen Provinz Yunnan MT
2023 Beijing Bohui Innovation Biotechnology Group Co, Ltd. meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Bohui Innovation Biotechnology Secures Blood Collection License in China’s Yunnan Province
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) added to S&P Global BMI Index
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Announces Board and Executive Changes
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Bohui Innovation Biotech Unit Gets Operation Permit for Plasma Center
Beijing Bohui Innovation Biotech Unit Sells Land for 108.2 Million Yuan
Bohui Innovation Biotechnology Unit to Sell Land-Use Rights For 108 Million Yuan; Shares Fall Nearly 4%
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) dropped from S&P Global BMI Index
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Beijing Bohui Innovation Biotechnology Group Co., Ltd.(XSEC:300318) added to S&P Global BMI Index
Beijing Bohui Innovation Biotechnology Group Co., Ltd. cancelled the transaction announced on February 17, 2020
Beijing Bohui Innovation Biotechnology Co., Ltd. cancelled the acquisition of 100% stake in Adchim SAS from Zhuhai Aosen Investment Co., Ltd.
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300318 Aktie
  4. Nachrichten Beijing Bohui Innovation Biotechnology Group Co., Ltd.
  5. Andere Sprachen